NCT05784467Not yet recruiting
Methamphetamine, PrEP, and Intersectional Stigma Study
Addressing Intersectional Stigma Through Coping, Resistance, and Resilience to Improve Methamphetamine Use and Factors Influencing PrEP Uptake Among Latino MSM: a Step Towards Ending HIV by 2030
Source: ClinicalTrials.gov · Last updated 19 Feb 2026
Brief summary (registry, in English)
The goal of this clinical trail is to test the developed eMPrISe study in HIV-negative, adult, Latino men who have sex with men (MSM) who use non-injection substances. The main questions it aims to answer are: * Can participation in the developed eMPrISe study reduce methamphetamine ('meth') use risk? * Can participation in the developed eMPrISe study improve preexposure prophylaxis (PrEP) cascade progression? Participants will participate in 12 weekly modules that: (1) build critical thinking skills, (2) identify and discuss the link between oppression and harmful behaviors, (3) take action, (4) voice and validate feelings and experiences, and (5) share knowledge and resources.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 13 Mar 2023
- Start date
- 15 Apr 2026
- Primary completion date
- 1 Aug 2026
- Lead sponsor
- Arizona State University
- Diseases
- HIV
- NCT number
- NCT05784467
What you commit to
- Study type: Interventional
- Planned participants: 20
- From 15 Apr 2026 to the primary completion date, 1 Aug 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- N/A
Who the study is looking for
- 18+ years of age
- cisgender male
- self-identify as Latino or Hispanic
- fluent in English or Spanish
- any sexual activity with men in the past 12 months
- HIV-negative
- moderate methamphetamine use risk (as determined by the the ASSIST assessment)
- experience of intersectional stigma within their social network in the past 12 months
- willing to provide written informed consent
Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.